Drug intelligence / Profile preview

inulin

Development stage
Phase 4
Lead developer
Sensus Healthcare
Modality
Microbiome Therapeutics
Administration
Oral, Intravenous
01

Overview

Inulin is a naturally occurring polysaccharide classified as a type of soluble dietary fiber and prebiotic. It consists of β-(2,1) linked linear fructans with varying chain lengths and is primarily derived from plants such as chicory root, garlic, onion, asparagus, and others[8]. Inulin is resistant to digestion by human enzymes in the stomach and small intestine; instead, it reaches the colon intact where it is fermented by beneficial gut bacteria[2][8]. This fermentation process supports the growth of healthy microbiota and leads to production of short-chain fatty acids. Pharmacologically, inulin has several uses: - As a diagnostic agent for measuring glomerular filtration rate (GFR), since it is freely filtered at the glomerulus but neither secreted nor reabsorbed by renal tubules[1][4][5]. - As a dietary supplement for its prebiotic effects—supporting gut health—and potential benefits in constipation relief, blood sugar regulation (especially for diabetes), lipid metabolism (cholesterol/triglycerides), mineral absorption enhancement (notably calcium), immune modulation via effects on intestinal barrier function and immune cell differentiation[2][3][6][8]. Mechanistically: - Inulin acts as a substrate for colonic bacteria. - It modulates immune responses by influencing T regulatory cells and promoting secretion of protective mucins. - It does not elevate blood glucose because it resists enzymatic breakdown into monosaccharides during digestion[1]. Inulin has been used widely as an ingredient in functional foods due to its fat-replacing properties and ability to improve texture.

Brand names
OraftiFrutafitFibruline
Other names
fructanβ-(2,1) linear fructanchicory root fiber

Beyond the preview

Go deeper on inulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call